AZIYO BIOLOGICS INC's ticker is AZYO and the CUSIP is 05479K106. A total of 18 filers reported holding AZIYO BIOLOGICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $49,659 | -94.9% | 32,887 | -85.7% | 0.00% | -100.0% |
Q4 2022 | $980,335 | -41.0% | 230,667 | 0.0% | 0.00% | -33.3% |
Q3 2022 | $1,661,000 | +1.8% | 230,667 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $1,631,000 | +18.9% | 230,667 | 0.0% | 0.00% | +50.0% |
Q1 2022 | $1,372,000 | -5.6% | 230,667 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $1,453,000 | -9.4% | 230,667 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $1,604,000 | -40.9% | 230,667 | -18.3% | 0.00% | -50.0% |
Q2 2021 | $2,712,000 | – | 282,249 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Birchview Capital, LP | 1,655,184 | $2,499 | 1.96% |
PERKINS CAPITAL MANAGEMENT INC | 275,329 | $416 | 0.39% |
Prosight Management, LP | 196,443 | $296,629 | 0.14% |
Indie Asset Partners, LLC | 26,500 | $40,015 | 0.05% |
Knollwood Investment Advisory, LLC | 58,962 | $89,033 | 0.02% |
Alyeska Investment Group, L.P. | 214,343 | $323,658 | 0.00% |
Tower Research Capital LLC (TRC) | 5,134 | $8 | 0.00% |
US BANCORP \DE\ | 625 | $944 | 0.00% |
WELLS FARGO & COMPANY/MN | 56 | $85 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |